title: Effect of cerebroventricular infusion of insulin and (or) glucose on hypothalamic expression of leptin receptor and pituitary secretion of LH in diet-restricted ewes.
abstract: The objective was to determine the effect of central infusion of insulin and (or) glucose on hypothalamic expression of leptin receptor and pituitary secretion of LH in the ewe. Twenty-two ovariectomized ewes (32 wk of age) were fitted with two lateral cerebroventricular (LCV) cannulae and fed 33% of NRC requirements for 8 wk. Ewes (n> or =5/group) were then infused, via LCV cannulae, with artificial cerebrospinal fluid (aCSF) or aCSF containing physiological concentrations of insulin (INS), glucose (GLU), or INS + GLU; the mass of each increasing linearly from Day 0 (mass = 0 units/h) to Day 8 (mass of INS = 80 mIU/hr and GLU = 10 mg/hr). Jugular serum was collected every 12 min for 4 hr on Days 0, 2, and 4. Ewes treated with INS or INS + GLU had greater (P<0.06) mean concentrations of LH than aCSF treated ewes on Day 2 (13.8+/-1.8 and 12.5+/-1.3 > 8.0+/-3.3 ng/ml). Furthermore, on Day 4, concentrations of LH in INS treated ewes exceeded that (P<0.07) of aCSF treated ewes (14.8+/-2.0 > 7.4+/-3.0 ng/ml). Expression of NPY mRNA did not differ between treatments (P = 0.87). Leptin receptor mRNA expression was dramatically reduced (P<0.0002) in INS+GLU versus aCSF treated ewes. These data provide evidence to suggest that insulin may be an important component of hypothalamic mechanisms regulating secretion of LH and expression of leptin receptors in undernourished ruminants.
authors.affiliation: Department of Animal Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Daniel
authors.forename: M G
authors.initials: MG
authors.lastname: Thomas
authors.forename: C S
authors.initials: CS
authors.lastname: Hale
authors.forename: J M
authors.initials: JM
authors.lastname: Simmons
authors.forename: D H
authors.initials: DH
authors.lastname: Keisler
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000378:metabolism; D002352:Carrier Proteins / Q000096:biosynthesis*; D005260:Female; D005508:Food Deprivation; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D017403:In Situ Hybridization / Q000662:veterinary; D007276:Injections, Intraventricular; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology*; D020738:Leptin / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood*; D009478:Neuropeptide Y / Q000096:biosynthesis / Q000235:genetics; D010052:Ovariectomy; D010902:Pituitary Gland / Q000378:metabolism*; D011673:Pulsatile Flow; D012333:RNA, Messenger / Q000378:metabolism; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D012756:Sheep / Q000097:blood / Q000502:physiology*; D015431:Weight Loss
chemical_list: D002352:Carrier Proteins; D007328:Insulin; D020738:Leptin; D009478:Neuropeptide Y; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D007986:Luteinizing Hormone; D005947:Glucose